Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OS ...
It was meant to be the watershed moment that changed Fallon Levy's life. In October 2018, in one of the most significant ...
Meningococcal infections can lead to severe, sometimes deadly, bloodstream infections, and severe swelling in the brain and ...
Researchers showed that 1.34 mg of Fotivda provided decreased tumor size and may be more tolerable than an 0.89-mg dose among patients with renal cell carcinoma.
A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the ...
Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
The recent surge has been due to the tremendous growth Lilly has achieved due to its highly popular GLP-1 drugs, including ...
Scientists from the University of Liverpool have found that a widely used blood pressure drug called rilmenidine may help ...
A recent study has found that the diabetes drug tirzepatide helps people with type 2 diabetes lower their blood sugar and ...
Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...
Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future ...
The results, published in The Lancet Diabetes and Endocrinology, showed that people in the sotagliflozin group had a 23 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results